BWAY News and Press, BrainsWay Ltd.

2026-03-11 10:32:23 ET BrainsWay Ltd. (BWAY) Q4 2025 Earnings Call March 11, 2026 8:30 AM EDT Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Brian Ritchie - Lifesci Advisors, LL...

2026-03-11 07:31:43 ET More on BrainsWay Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag BrainsWay down after investment in Canadian mental care provider Seeking Alpha’s Quant Rating on BrainsWay Hist...

Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage  Full Year 2025 Revenue Increased by Approximately 27% YoY to $52.2 Million, and Net Income Incr...

Sagimet Biosciences Inc. (SGMT) is expected to report $-0.43 for Q4 2025 Serve Robotics Inc. (SERV) is expected to report $-0.49 for Q4 2025 Swiss Water Decaffeinated Coffee Inc (SWSSF) is expected to report $0.02 for Q4 2025 Verrica Pharmaceuticals Inc. (VRCA) is expected to report $...

2026-03-10 11:01:45 ET More on BrainsWay Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag BrainsWay down after investment in Canadian mental care provider Seeking Alpha’s Quant Rating on BrainsWay Hist...

2026-03-08 09:30:25 ET More on Avino Silver & Gold Mines Ltd., Harmony Gold Mining, etc. Zumtobel Group AG (ZMTBY) Q3 2026 Earnings Call Transcript Zumtobel Group AG 2026 Q3 - Results - Earnings Call Presentation Buy Oracle's 'Bubble Fears' Before Next Week's Q3 ...

2026-03-05 09:30:16 ET GAD Therapies Market Set to Explode to $4.26B by 2033 as Demand Rockets for Innovative Anxiety Solutions New York, NY –March 5, 2026 – Market News Updates News Commentary – Treatments for Generalized Anxiety Disorder (GAD) ...

BURLINGTON, Mass. and JERUSALEM, March 04, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled new clinical data showing a significantly faster, noninvasive way to treat depression without compromising the efficacy of one of psychiatry’s most impactful treatments...

BURLINGTON, Mass. and JERUSALEM, Feb. 25, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today announced that it will report its fourth quarter and...

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that management will participate in one-o...